Table 1. Selected drugs for group negotiation under pooled procurement, India, 2019–2020.

Drug, by class	Stock-keeping unit	Route of administration	Listed in national list of essential medicines
Anticoagulant
Enoxaparin sodium	20, 40, 60 and 80 mg	Parenteral	Yes
Antiemetic
Aprepitant	80 and 125 mg	Oral	No
Antifungal
Posaconazole	200 mg	Syrup	No
Voriconazole	50 and 200 mg	Oral and parenteral	No
Antimicrobial
Meropenem	500 and 1000 mg	Parenteral	Yes
Teicoplanin	200 and 400 mg	Parenteral	No
Antineoplastic
Bevacizumab	100 and 400 mg	Intravenous	No
Bortezomib	1.0, 2.0, 2.5 and 3.5 mg	Parenteral	Yes
Capecitabine	500 mg	Oral	Yes
Carboplatin	150 and 450 mg	Intravenous	Yes
Cetuximab	100 mg	Intravenous	No
Cisplatin	10 and 50 mg	Intravenous	Yes
Crizotinib	200 and 250 mg	Oral	No
Cytarabine	100, 500 and 1000 mg	Intravenous	Yes
Dasatinib	50 and 70 mg	Oral	No
Docetaxel	20, 80 and 120 mg	Intravenous	Yes
Doxorubicin	10 and 50 mg and 50 mg (powder to be reconstituted)	Intravenous	Yes
Epirubicin	10, 50 and 100 mg	Intravenous	No
Erlotinib	100 and 150 mg	Oral	No
Gefitinib	250 mg	Oral	Yes
Gemcitabine	200, 1000 and 1400 mg	Intravenous	Yes
Ifosfamide	1000 and 2000 mg	Intravenous	Yes
Imatinib	100 and 400 mg	Oral	Yes
Imipenem+cilastatin	500 mg	Intravenous	No
Irinotecan	40 and 100 mg	Intravenous	Yes
Lapatinib	250 mg	Oral	No
L-Asparaginase	5000 and 10 000 IU	Intravenous	Yes
Nilotinib	150 and 200 mg	Oral	No
Oxaliplatin	50 and 100 mg	Intravenous	Yes
Paclitaxel	30, 100, 260 and 300 mg	Intravenous	Yes
Pemetrexed	100 and 500 mg	Intravenous	No
Rituximab	100 and 500 mg	Intravenous	Yes
Sunitinib	12.5, 25.0 and 50.0 mg	Oral	No
Temozolomide	20, 100 and 250 mg	Oral	Yes
Trastuzumab	150 and 440 mg	Intravenous	Yes
Growth factor
Filgrastim	300 μg	Parenteral	Yes
Hormonal agent
Leuprolide acetate	3.75, 11.25, 22.50 and 45.00 mg	Parenteral	Yes
Intravenous contrast
Iohexol	300 mg	Intravenous	Yes
Parenteral iron
Ferric carboxymaltose	100 and 500 mg	Intravenous	No

IU: international unit.